ストックスクリーナーアプリを入手
17.50
1.35%
-0.24
前日終値:
$17.74
開ける：
$17.56
24時間の取引高:
323.58K
Relative Volume:
6.03
時価総額：
$825.55M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-0.68%
1か月 パフォーマンス:
+0.00%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$16.50
$18.43
1週間の範囲:
$16.50
$18.43
52週間の値動き範囲:
$16.41
$18.43
Odyssey Therapeutics Inc Stock (ODTX) Company Profile
Compare ODTX vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ODTX
Odyssey Therapeutics Inc
|
17.50 | 836.87M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.03B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
638.88 | 67.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
806.46 | 50.76B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
297.45 | 40.12B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
151.56 | 32.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Odyssey Therapeutics Inc (ODTX) 最新ニュース
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Odyssey Therapeutics hits $900M valuation in Nasdaq debut, stock climbs 13% before diving lower - MSN
IPO Tracker 2026: Parabilis follows hefty Regeneron deal with IPO push - BioSpace
Odyssey Therapeutics (ODTX) Stock Analysis Report | Financials & Insights - Benzinga
Simeon George Discloses Investment at Odyssey Therapeutics with 8.0% Stake - TradingView
SR One funds disclose 8% Odyssey Therapeutics (ODTX) stake after IPO - Stock Titan
TPG funds take 7.8% Odyssey Therapeutics (ODTX) stake via $25M share purchase - Stock Titan
Odyssey Therapeutics (ODTX) 10K Form and Latest SEC Filings 2026 - MarketBeat
Odyssey Therapeutics (ODTX) Stock Chart and Price History 2026 - MarketBeat
Dimension Management Discloses Investment at Odyssey Therapeutics with 7.1% Stake - TradingView
Jeito II S.L.P. Discloses Investment in Odyssey Therapeutics with 7.8% Stake - TradingView
What is the current Price Target and Forecast for Odyssey Therapeutics, Inc. (ODTX) - Zacks Investment Research
Immunology drug developer Odyssey seeks US IPO again - MSN
Immune system biotech odyssey seeks $238.3 million in US IPO - MSN
ODTX Stock Chart | ODYSSEY THERAPEUTICS INC (NASDAQ:ODTX) - ChartMill
Odyssey Therapeutics Prices $304 Million Upsized IPO and Concurrent Private Placement - Global Legal Chronicle
Odyssey Therapeutics (ODTX) Stock Trends and Sentiment 2026 - MarketBeat
ODTX Price History for Odyssey Therapeutics Stock - Barchart.com
ODYSSEY THERAPEUTICS INC (ODTX) - Minichart
Major Investor Quietly Makes a Massive New Bet on Odyssey Therapeutics - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
ODTX | Odyssey Therapeutics, Inc. Common Insider Trading - Quiver Quantitative
Major Insider Move Signals Growing Confidence in Odyssey Therapeutics - TipRanks
ODTX News Today | Why did Odyssey Therapeutics stock drop today? - MarketBeat
Total assets of Odyssey Therapeutics, Inc. – NASDAQ:ODTX - TradingView
Odyssey Therapeutics, Inc. Statistics – NASDAQ:ODTX - TradingView
ODTX Stock Price, Quote & Chart | ODYSSEY THERAPEUTICS INC (NASDAQ:ODTX) - ChartMill
Odyssey Therapeutics, Inc. Dividends – NASDAQ:ODTX - TradingView
Odyssey Therapeutics, Inc. Revenue Breakdown – NASDAQ:ODTX - TradingView
Odyssey Therapeutics, Inc. Earnings and Revenue – NASDAQ:ODTX - TradingView
ODYSSEY THERAPEUTICS INC Statistics – BOATS:ODTX - TradingView
Diluted earnings per share (diluted EPS) of Odyssey Therapeutics, Inc. – NASDAQ:ODTX - TradingView
Odyssey Therapeutics Hits $900M Valuation In Nasdaq Debut, Stock Climbs 13% Before Diving Lower - Stocktwits
ODTX Price Today: Odyssey Therapeutics, Inc. Stock Price, Quote & Chart - MEXC Exchange
Basic earnings per share (basic EPS) of ODYSSEY THERAPEUTICS INC – BOATS:ODTX - TradingView
Non-operating income (total) of ODYSSEY THERAPEUTICS INC – BOATS:ODTX - TradingView
Operating income of Odyssey Therapeutics, Inc. – NASDAQ:ODTX - TradingView
Immunology drug developer Odyssey prices upsized IPO - MSN
Odyssey raises $304 million in upsized Nasdaq debut - The Pharma Letter
ODTX | Odyssey Therapeutics, Inc. Common Institutional Ownership - Quiver Quantitative
ODTX: Odyssey Therapeutics, Inc.Price & EPS Surprise - Zacks Investment Research
Odyssey Therapeutics, Inc. (ODTX) Gross Margin (TTM) - Zacks Investment Research
Odyssey Therapeutics, Inc. (ODTX) Price - Zacks Investment Research
Odyssey Therapeutics, Inc. (ODTX) Gross Profit (TTM) - Zacks Investment Research
Odyssey Therapeutics, Inc. (ODTX) Net Income (Quarterly) - Zacks Investment Research
Odyssey Therapeutics, Inc. (ODTX) Total Expenses (TTM) - Zacks Investment Research
Dividend HistoryOdyssey Therapeutics, Inc. (ODTX) - Zacks Investment Research
Odyssey Therapeutics, Inc. (ODTX) Total Long Term Debt (Quarterly) - Zacks Investment Research
Odyssey Therapeutics, Inc. (ODTX) Earnings Yield (TTM) - Zacks Investment Research
Odyssey Therapeutics, Inc. (ODTX) Revenue (TTM) - Zacks Investment Research
Odyssey Therapeutics, Inc. (ODTX) Enterprise Value - Zacks Investment Research
Odyssey Therapeutics Inc (ODTX) 財務データ
Odyssey Therapeutics Inc (ODTX) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Odyssey Therapeutics Inc (ODTX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Dimension Capital II, L.P. | Director |
May 08 '26 |
Buy |
18.00 |
1,111,111 |
19,999,998 |
3,333,516 |
| SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner |
May 11 '26 |
Buy |
18.00 |
555,555 |
9,999,990 |
1,831,383 |
| SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner |
May 11 '26 |
Sale |
18.00 |
1,780 |
32,040 |
440,981 |
| LEIDEN JEFFREY M | Director |
May 08 '26 |
Buy |
20.00 |
5,000 |
100,000 |
270,198 |
| Haas Jason | Chief Financial Officer |
May 08 '26 |
Buy |
20.00 |
1,000 |
20,000 |
62,908 |
| Li Nan (LN) | Director |
May 11 '26 |
Buy |
18.00 |
1,111,111 |
19,999,998 |
3,333,516 |
| Chu Shelley | Director |
May 11 '26 |
Buy |
18.00 |
11,111 |
199,998 |
11,111 |
2.98%
1.33%
大文字化:
|
ボリューム (24 時間):